Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)

Delayed Data
As of Jan 20
 -0.38 / -4.77%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 23.50, with a high estimate of 50.00 and a low estimate of 14.00. The median estimate represents a +210.03% increase from the last price of 7.58.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -30.61%
Growthannually 52.80%


Growthquarterly 61.33%
Growthannually --
Key to the earnings and sales forecast charts.